Back to Resource Center

Regulatory Assessment — Learning about Expanded Access and Potential of the Levonorgestrel Intrauterine System (LEAP LNG-IUS)

Regulatory Assessment — Learning about Expanded Access and Potential of the Levonorgestrel Intrauterine System (LEAP LNG-IUS)

With funding from the Bill & Melinda Gates Foundation, FHI 360 and partners Population Services
International (PSI) and WCG Cares are implementing the Learning about Expanded Access and Potential of
the LNG-IUS (LEAP LNG-IUS) Initiative. The project is intended to help determine if and how expanded
access to the levonorgestrel intrauterine system (LNG-IUS) — a long-acting contraceptive — could
increase contraceptive use and continuation rates in sub-Saharan Africa. Activities include research
among women and providers in Nigeria and Zambia as well as demand forecasting in Kenya, Nigeria and
Zambia. The findings from the project will help stakeholders better understand the potential demand for
the LNG-IUS, experiences among users and providers, and continuation rates and cost-effectiveness of
the LNG-IUS compared with other long-acting reversible contraceptive (LARC) methods.

November 2018

Click to view Reports

Click for full info +

Regulatory Assessment — Learning about Expanded Access and Potential of the Levonorgestrel Intrauterine System (LEAP LNG-IUS)

November 2018
In this Technical Brief:
Topic(s):

  • Regulatory Assessment
  • Levonorgestrel Intrauterine System
  • LEAP LNG-IUS
Region(s):

  • United States

Full Info:


Resource Type:

Reports

Citation:

WCG Cares, FHI360, Population Services International

Product type(s):

  • Contraceptives

Topic(s):

  • Development
  • Regulatory

Region(s)

  • United States

URL of resource:

https://marketbookshelf.com/wp-content/uploads/2019/05/LEAP-LNG-IUS-Report_WCG_FHI360_Final_Nov2018-v.topost.pdf

Back to Resource Center